Investor profile
Pictet has backed 8 European tech companies across 11 funding rounds between 2006 and 2025, joining rounds totalling €612M. Most active in Healthtech and Cleantech. Data as of 6 Aug 2026.
Also recorded as: Pictet Group
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Azafaros | Netherlands | 1 | €132M |
| Fairmat | France | 2 | €86M |
| Infogrid | UK | 1 | €83M |
| Antag Therapeutics | Denmark | 1 | €80M |
| NovImmune | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Azafaros | Series B | €132M | 2025-05 |
| Infogrid | Series B | €83M | 2023-04 |
| Antag Therapeutics | Series A | €80M | 2024-12 |
| Taurus Group |
| 2 |
| €77M |
| Taurus Group | Switzerland | 1 | €60M |
| Le Collectionist | France | 1 | €60M |
| Unique | Switzerland | 2 | €34M |
| Series B |
| €60M |
| 2023-02 |
| Le Collectionist | Other | €60M | 2022-12 |
| Fairmat | Series B | €52M | 2025-04 |
| NovImmune | Series C | €41M | 2009-05 |
| NovImmune | Series B | €36M | 2006-06 |
| Fairmat | Other | €34M | 2022-11 |
| Unique | Series A | €29M | 2025-02 |
